MedTrace Logo

Genetic Testing Decision Aid

NCT05470920 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2025-08-13

No results posted yet for this study

Summary

This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer

Conditions

  • Epithelial Ovarian Carcinoma
  • Pancreas Adenocarcinoma

Interventions

BEHAVIORAL

Electronic Decision Aid

Decision aid followed by an appointment with an oncologist. Will complete surveys/questionnaires

BEHAVIORAL

Pre-Test Genetic Counseling

Receive pretest counseling with a genetic counselor. Will complete surveys/questionnaires

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Daniel C. Chung, MD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-14
Primary Completion
2026-09-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05470920 on ClinicalTrials.gov